Evidence map›Paper›PMID 42827887›Full record

ArticleAmerican journal of preventive cardiology2026

Scaling a Lipid-Lowering Clinical Decision Support Intervention Across U.S. Health Systems: Lessons Learned from the PROMPT-LIPID Multicenter Study.

Bashar Kadhim, Farah Yasmin, Ralph Riello, Ambrish A Pandit, David Davidson, Erica Davis, Gemme Campbell Salome, J A Randy Englert, Laney K Jones, Melissa Martin and 8 more

Abstract read
In one paragraph

Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Bashar KadhimClinical and Translational Research Accelerator, Yale University, New Haven, CT 06511, USA.
Farah YasminClinical and Translational Research Accelerator, Yale University, New Haven, CT 06511, USA.
Ralph RielloClinical and Translational Research Accelerator, Yale University, New Haven, CT 06511, USA.
Ambrish A PanditAmgen Inc., Thousand Oaks, CA, USA.
David DavidsonEndeavor Health Medical Group, 9650 Gross Point Rd., Skokie, IL 60076-5080, USA.
Erica DavisAmgen Inc., Thousand Oaks, CA, USA.
Gemme Campbell SalomeAmgen Inc., Thousand Oaks, CA, USA.
J A Randy EnglertJohn Ochsner Heart and Vascular Institute, 1514 Jefferson Highway, New Orleans, LA 70121, USA.
Laney K JonesAmgen Inc., Thousand Oaks, CA, USA.
Melissa MartinClinical and Translational Research Accelerator, Yale University, New Haven, CT 06511, USA.
F Will PohlmanDivision of Cardiology, Washington University School of Medicine, 660 S. Euclid Ave, MSC 8086-43-13, USA.
Chloe FerrisDivision of Cardiology, Washington University School of Medicine, 660 S. Euclid Ave, MSC 8086-43-13, USA.
Thomas M MaddoxDivision of Cardiology, Washington University School of Medicine, 660 S. Euclid Ave, MSC 8086-43-13, USA.
Nihar R DesaiDepartment of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06511, USA.
Sharath SubramanianCentraCare Heart & Vascular Center, 1406 6th Ave N, St Cloud, MN 56303, USA.
Yu YamamotoClinical and Translational Research Accelerator, Yale University, New Haven, CT 06511, USA.
Tariq AhmadDepartment of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06511, USA.
F Perry WilsonClinical and Translational Research Accelerator, Yale University, New Haven, CT 06511, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The PRagmatic study Of Messaging to Providers about Treatment of HyperLIPIDemia (PROMPT-LIPID) single-system pragmatic, randomized trial demonstrated that an electronic health record (EHR)-embedded clinical decision support (CDS) intervention increased lipid-lowering therapy (LLT) intensification among patients with very high-risk atherosclerotic cardiovascular disease (ASCVD). To support broader dissemination, the parent PROMPT-LIPID Multicenter Scaling Study uses a prospective stepped-wedge design to evaluate the clinical effectiveness of the intervention across U.S. health systems using the Epic EHR platform. The present study describes the multicenter pre-implementation and deployment processes, including the barriers, mitigation strategies, and infrastructure associated with adapting and activating the PROMPT-LIPID CDS intervention across participating health systems. Methods: We conducted a narrative synthesis of implementation lessons identified through investigator and site meetings, site reports, regulatory and contracting documentation, CDS build and validation activities, pharmacy workflow reviews, and implementation milestone records. Findings were organized into three practical domains: site onboarding and administrative processes, technological implementation, and clinical and operational workflow integration. Results: Eight external health systems were initially engaged, of which three (37.5%) proceeded to implementation and reached active-alert go-live. Implementation challenges clustered into three areas. Site-onboarding and administrative challenges included variable contracting and regulatory timelines, multilevel governance requirements, and difficulties sustaining site engagement; these were addressed through parallel initiation of regulatory and build activities, centralized coordination, standardized onboarding, and regular cross-site communication. Technological challenges included heterogeneous Epic configurations, inconsistent CDS logic and data definitions, dependence on local analytics, data-harmonization requirements, and secure data-transfer constraints. These were mitigated through site-specific mapping, a prepackaged XML toolkit, standardized data definitions, and a parameterized SQL framework deployed through Epic Template Reports. Operational challenges included clinician concerns regarding workflow integration, alert fatigue, competing priorities, variation in prescribing practices, and medication-access barriers. These were addressed through iterative CDS refinement, stakeholder engagement, silent validation, and linkage of CDS recommendations to pharmacy support pathways. Conclusions: This manuscript presents an early narrative report of multicenter implementation lessons from the PROMPT-LIPID CDS intervention, describing practical barriers, solutions, and deployment infrastructure encountered across three external health systems that reached implementation. These findings may inform future multicenter deployment of EHR-based lipid-management CDS interventions; however, broader evaluation is needed to establish the generalizability, reproducibility, and sustainability of this approach. Clinical effectiveness and implementation outcomes, including LLT intensification, alert-firing, clinician-action, and adoption rates from the parent stepped-wedge study, will be reported separately.

Indexed as

ASCVDCardiovascular preventionClinical decision supportElectronic health recordsGuideline-directed therapyHealth systemsImplementation scienceLDL-CLipid loweringMulticenter implementationPharmacy workflowQuality improvement

Identifiers

PMID42827887
PMCPMC13632159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.